Genzyme Goes After Sandoz Again Over Hectorol
Genzyme lodged the suit Friday in the U.S. District Court for the District of Delaware, saying an abbreviated new drug application Sandoz recently submitted to the U.S. Food and Drug Administration infringes the patents-in-suit.
According to the suit, the FDA approved Hectorol in April 2000. In April 2008, Genzyme submitted an application to the agency...
To view the full article, register now.